BL-1833

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBL-1833
Drug Alias NameBL-1833
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsCluster Headache
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBioglan Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioglan Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsCluster Headache

Other Information

ATC CodeN/A
Related LinksN/A